Oxford-AstraZeneca COVID-19 vaccine trial put on hold after one unexplained illness

AstraZeneca Plc has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. The study is testing a COVID-19 vaccine being developed by AstraZeneca and the University of Oxford researchers at various sites, including the United Kingdom.